Description:

Comparable Study of Different Radiation Dose in Esophageal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01937208

Link:

https://clinicaltrials.gov/show/NCT01937208

Keywords:
Versions (1) ▾
  1. 12/14/19
Copyright Holder:
See clinicaltrials.gov
Uploaded on:

December 14, 2019

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Esophageal Carcinoma NCT01937208

Eligibility Esophageal Carcinoma NCT01937208

Inclusion Criteria
histological or cytologic diagnosis of esophageal carcinoma
ecog performance status 0-1
age:18-70 years
joined the study voluntarily and signed informed consent form
patients must not have received any prior anticancer therapy
unresectable disease, or refuse surgery.stage ⅰ-ⅳa(ajcc 2009)
target lesions can be measured according to recist criteria
no serious system dysfunction and immuno-deficiency, adequate organ function including the following: hemoglobin ≥9 g/dl, wbc≥3x109/l, neutrophils (anc )≥1.5x109/l, platelet count ≥100x 109/l, tbil<1.5 x uln, alt and ast ≦ 2.5 x uln, creatinine ≦ 1.5 x uln
use of an effective contraceptive for adults to prevent pregnancy
life expectancy of more than 3 months
Exclusion Criteria
multiple carcinomas of the esophagus,
biopsy-proven invasion of the tracheobronchial tree or tracheoesophageal fistula,
metastatic disease (m1),
a primary tumor that extended to within 2 cm of the gastroesophageal junction,
prior chemotherapy, prior thoracic radiation, surgical resection of the primary tumor,
concurrent pregnancy or lactation, history of a second malignancy other than nonmelanoma skin cancer